Clinical Trial

Single High-dose Brachytherapy for Giant Osteosarcoma Masses

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study is a prospective, single-arm, phase II, single-center study. Patients with locally unresectable giant osteosarcoma masses who meet the criteria are enrolled in the experimental group, and all patients receive a single dose of 10Gy of implantable brachytherapy. Record treatment-related acute events during and after treatment. Follow up on survival and local control after treatment ends, marking the end of the trial treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-24; most recent amendment 2024-08-05.
Trial Details
NCT Number NCT06524778
Lead Sponsor Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Conditions Osteosarcoma
Enrollment 16 participants
Start Date 2024-08-30
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-07